Clinical Trials Logo

Cancer clinical trials

View clinical trials related to Cancer.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05187130 Completed - Cancer Clinical Trials

The Effect of Mindfulnes Program on Stress, Depression and Psychological Well-being in Cancer Patients

Start date: July 20, 2021
Phase: N/A
Study type: Interventional

Study design A single blinded, randomized controlled experimental design was used. The study complied with guidelines outlined under the Consolidated Standards of Reporting Trials (CONSORT) checklist. Sample and Participants The study was carried out in July-December 2021 with the participation of cancer patients who were treated at a university hospital in Istanbul/Turkey. Inclusion criteria; Patients aged 18 and over, volunteering to participate in the study, conscious and without communication problems, who did not take any course or practice (intervention?) on anxiety, tension, depression symptoms and coping with stress were included in the study. Sample size and randomization The sample number was calculated using the GPower 3.1.9 version program. At an effect size of 0.5 and an error level of 0.05 [alpha], the required sample size was determined to be at least 54 individuals for each group. A power analysis was performed considering the number of samples and the values of the data obtained from a similar study in the literature (Lee et al., 2020). The power of the analysis made with this sample size was determined as 93.1%. Considering the losses during the study, the sample number for each group was determined as 60 people. The groups of participants who agreed to participate in the study were determined by the program with the randomization URL In order to distribute the numbers to the groups, the numbers from 1 to 120 were randomly assigned to the two groups, assuming that set 1 would represent the intervention group and set 2 would represent the control group. In line with the program, the order of the patients forming the sample group was determined by randomization. A total of 130 patients, 65 in the intervention group and 65 in the control group, were included in the study. 5 participants in the intervention group who did not want to participate and died during the study, and 5 participants in the control group who did not want to participate and died during the study were not included in the evaluation. In the study, the results of a total of 120 patients, 60 in the intervention group and 60 in the control group, were analyzed.

NCT ID: NCT05171426 Completed - Cancer Clinical Trials

Incidental Cancer in Familial Adenomatous Polyposis

Start date: January 1, 2018
Study type: Observational

Colectomy is life-saving in patients with familial adenomatous polyposis (FAP) because cancer development is inevitable in individuals with this disease. In this study, we aimed to determine the incidence of incidental malignancy in surgical specimens from patients who underwent colectomy for FAP. Prophylactic colectomy should be performed in patients with FAP, as colorectal cancer transformation is inevitable in these individuals. The possibility of incidental cancer identified via histopathological analysis of colectomy specimens should be kept in mind in these patients.

NCT ID: NCT05127668 Completed - Cancer Clinical Trials

Efficacy of AirGLovE in Difficult Venous Access

Start date: March 29, 2019
Phase: N/A
Study type: Interventional

To determine whether Airgloveā„¢ warming device dilates upper limb veins to the same degree as the warm water immersion (WWI) method.

NCT ID: NCT05076916 Completed - Cancer Clinical Trials

The Effectiveness of the Web-based Education Programme Among Cancer Patients

Start date: May 2014
Phase: N/A
Study type: Interventional

This study aims to develop a web-based education program among cancer patients undergoing treatment of systemic chemotherapy and to evaluate the effect of the program on symptom control, quality of life, self-efficacy, and depression. Evaluating the effect of the web-based education programme among cancer patients will be useful in planning appropriate remote nursing interventions to increase the symptom control and quality of life of patients. A web-based education program was prepared in line with patient needs, evidence-based guidelines, and expert opinions and tested with 10 cancer patients. A single-blind, randomised controlled study design was applied. Pre-tests were applied to 60 cancer patients undergoing systemic chemotherapy, and the patients (intervention:30, control: 30) were randomized. The intervention group used the web-based education program for three months, and they were allowed to communicate with the researchers 24/7 via the website. The effectiveness of the web-based education program at baseline and after 12 weeks evaluated.

NCT ID: NCT05069662 Completed - Cancer Clinical Trials

Impact of the COVID-19 Pandemic on Drug Use and Monitoring of Cancer Patients

Start date: October 5, 2021
Study type: Observational

The COVID-19 pandemic has profoundly changed the organisation of care. Teleconsultation has replaced hospital medical consultations in order to reduce the risk of patient exposure to the virus. Within the framework of the Oncoral multidisciplinary outpatient / hospital program of follow-up, carried out by the Hospices Civils de Lyon for ambulatory patients treated with oral anticancer drugs, interviews with the pharmacist and/or nurse, which were previously organised face-to-face, have been replaced by telephone interviews, ensuring continuity of follow-up for patients without having to come to the hospital. This study focuses on a telephone survey to describe the impact of the COVID-19 pandemic health crisis on the drug exposure of cancer patients followed in the Oncoral program, their treatment management, their perception of teleconsultation and their IT resources for remote monitoring.

NCT ID: NCT05062525 Completed - Cancer Clinical Trials

Immune Response to COVID-19 Vaccine in Immunotherapy (IO) and Non-IO Treated Cancer Patients

Start date: September 28, 2021
Study type: Observational

Evaluation of antibody response against SARS-CoV-2 vaccination in patients treated with IO-treatment, in comparison with antibody titers in patients treated with non-IO treatment.

NCT ID: NCT05054569 Completed - Cancer Clinical Trials

Developing and Pre-Testing an eHealth Group Intervention for Young Adult Cancer Survivors

Start date: September 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to develop and pre-test an eHealth group intervention for young adult cancer survivors.

NCT ID: NCT05041946 Completed - Cancer Clinical Trials

Patient Controlled Methylphenidate for Cancer Related Fatigue: A Double Blind, Randomized, Placebo Controlled Trial

Start date: July 16, 2003
Phase: Phase 3
Study type: Interventional

To determine the effectiveness of patient controlled methylphenidate as compared to placebo for the management of cancer related fatigue as determined by the Functional Assessment of Chronic Illness Therapy (FACIT)-F Fatigue score.

NCT ID: NCT05012904 Completed - Pain Clinical Trials

Using Parental Support to Reduce Venipuncture Pain and Anxiety in Children With Cancer

Start date: June 1, 2021
Phase: N/A
Study type: Interventional

This study aims to determine whether parental support reduces venipuncture pain and anxiety in children with cancer.

NCT ID: NCT05010239 Completed - Cancer Clinical Trials

The Immediate Effect of Mindfulness-Based Supportive Therapy on Palliating Suffering in Palliative Care Cancer Patients

Start date: August 1, 2020
Phase: N/A
Study type: Interventional

The was a parallel group, single-blinded, randomized controlled trial comparing the effectiveness of 30-minute mindfulness-based supportive therapy versus supportive listening in reducing suffering among patients with cancer. This study was conducted in the University Malaya Medical Centre, from 1st august 2020 to 31 December 2020.